15 results

Great Place to Work certifies organisations that excel in creating, supporting and delivering a high-trust work environment. Photograph: iStock

The Great Place to Work Certification Programme is a three-year framework designed to build and sustain a high-performance culture in organisations. T(...)

The Swiss stock exchange in Zurich.

Early data in Swiss share trading on Monday indicated banks and fund managers in the EU were directing their deals towards three destinations - the Zu(...)

The global economy is facing a ‘delicate moment’, the International Monetary Fund warned on Tuesday. Photograph: Andrew Caballero-Reynolds/AFP/Getty

Fresh tariff rhetoric from US president Donald Trump affected global stocks on Tuesday with Europe’s benchmark Stoxx 600 index down 0.3 per cent. Add(...)

Shares in Novartis were up close to 4 per cent as investors welcomed the news. Photograph:  Reuters

Novartis plans to spin off its Alcon eyecare business to shareholders and buy back up to $5 billion in stock as chief executive Vas Narasimhan refocus(...)

Vas Narasimhan:  he will take over as Novartis CEO  in 2018

Novartis chief executive Joe Jimenez will step down on February 1st and hand over to drug development chief Vas Narasimhan to decide the fate of $50 b(...)

Alcon Ireland said it spent €9.2 million  on developing its manufacturing capacity in Cork last year

The Irish division of eyecare business Alcon, which last year marked 25 years in Cork, saw profits and turnover decline in 2016 after incurring big co(...)

Alcon Laboratories Ireland said the company’s 2015 performance was “strong” due to increased demand for its lenses. Photograph: Alastair Miller/Bloomberg

Sales at the Irish division of Novartis eyecare business Alcon jumped more than 5 per cent to €41.78 million last year. However, profit before tax fe(...)

The logo of Swiss pharmaceutical company Novartis is seen at the company’s plant in Hueninge, France

Swiss drugmaker Novartis has appointed a new head of its Alcon eye care division after the company fell short of fourth-quarter earnings expectations(...)

The Novartis AG headquarters stand in Basel, Switzerland.  The company said its earnings were hit in the second quarter by a stronger US dollar. Photograph: Peter Frommenwiler/Bloomberg

Pharmaceutical firm Novartis saw its second quarter earnings fall by 7 per cent as the strength of the US dollar hit sales. The company said it(...)

Swiss drug maker reported first-quarter profits beating estimates with operating income of $3.55 billion. Photograph: Reuters.

Novartis, the world’s biggest drugmaker by sales, reported first-quarter profits that beat analysts’ estimates as the company begins to benefit from a(...)

  • 1
  • 2
  • Next
  • Last »